Standout Papers
Citation Impact
Citing Papers
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
2004 StandoutNobel
Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer
2008
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers-A review
1995
Hallmarks of Cancer: The Next Generation
2011 Standout
Altered Expression of Metastasis-Associated and Regulatory Molecules in Effusions from Breast Cancer Patients
2004
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2002
mTOR Signaling in Growth Control and Disease
2012 Standout
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 Standout
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
1999 StandoutNatureNobel
Vascular targeting—a new approach to the therapy of solid tumors
1994
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
VEGF mRNA is Reversibly Stabilized by Hypoxia and Persistently Stabilized in VEGF-Overexpressing Human Tumor Cell Lines
1995
VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer
1999
Hypoxia‐inducible factor‐1α is associated with angiogenesis, and expression of bFGF, PDGF‐BB, and EGFR in invasive breast cancer
2005
The Hallmarks of Cancer
2000 Standout
Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications
2008
Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells
2002 StandoutNobel
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
1994 Standout
Lymphangiogenesis in development and human disease
2005 StandoutNature
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
Angiogenesis and expression of thymidine phosphorylase by inflammatory and carcinoma cells in ductal carcinomain situ of the breast
1999
Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis
1995
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
The microenvironment of the tumour–host interface
2001 StandoutNature
Review: The Integrin αvβ3: Angiogenesis and Apoptosis
1995
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
1995
Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.
1998
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis
1995
Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops
1998
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Mechanisms of angiogenesis
1997 StandoutNature
Molecular Mechanisms of Developmental and Tumor Angiogenesis
1994
Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis
1998
Angiogenesis in cancer, vascular, rheumatoid and other disease
1995 Standout
The angiogenic switch in carcinogenesis
2009
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
1996 StandoutNature
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer
2006
Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and theor relation to estradiol receptor (ER) status
1997
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
1995
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 Standout
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer
2003
Angiogenesis as a therapeutic target
2005 StandoutNature
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
2011 StandoutNature
Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer
2000
Prognostic Value of Vascular Endothelial Growth Factor in Breast Cancer
2000
Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
1999
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Life with Oxygen
2007 StandoutScienceNobel
Antiangiogenesis for cancer therapy
1997
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
1997 StandoutScience
Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment
2000
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
1999 StandoutScience
Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer.
1999
Wound Healing--Aiming for Perfect Skin Regeneration
1997 StandoutScience
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
pVHL 19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation
1998 StandoutNobel
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
1999 StandoutScience
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
1997 StandoutNobel
TARGETED CONTRAST AGENTS IN MR IMAGING
1996
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
1993
Requirement of Vascular Integrin α v β 3 for Angiogenesis
1994 StandoutScience
Angiogenesis in Endocrine Tumors
2003
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Geometric Control of Cell Life and Death
1997 StandoutScience
Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.
2000
Surface molecular recognition
2001 StandoutNobel
Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer
2005
Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.
1998
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004
Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer
2002
Works of S Meli being referenced
Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma ? results of a multiparametric study
1995
Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma
1992 Standout
Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
1992
Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications
1997
Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
2006
Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer
1992